Exchange: NYSE
Industry: Health Care Equipment & Services
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
10,253,300 | 8,918,300 | 8,837,000 | 8,922,400 | 8,574,300 |
Premiums Earned |
8,686,100 | 7,728,900 | 7,636,600 | 7,663,800 | 7,367,400 |
Total Investment Income |
239,500 | 215,400 | 222,800 | 240,600 | 203,300 |
Realized Gains (Losses) |
31,600 | 19,100 | 10,500 | 58,300 | 30,200 |
Other Operating Income |
1,296,100 | 954,900 | 967,100 | 959,700 | 973,400 |
Losses, Claims & Reserves |
6,582,900 | 6,364,600 | 6,391,600 | 6,368,400 | 6,035,800 |
Losses, Benefits & Adjustments |
6,085,900 | 5,847,700 | 5,908,300 | 5,857,500 | 5,593,200 |
Long Term Insurance Reserves |
497,000 | 516,900 | 483,300 | 510,900 | 442,600 |
Selling, General & Admin. Expenses & Other |
2,268,100 | 1,673,700 | 1,683,400 | 1,703,800 | 1,733,000 |
Selling, General & Admin. Expenses |
1,914,300 | 1,673,700 | 1,375,000 | 1,380,200 | 625,400 |
Other Selling, General & Admin. Expense |
1,629,300 | 1,400,900 | 1,375,000 | 1,380,200 | 625,400 |
Underwriting & Commissions |
285,000 | 272,800 | NA | NA | NA |
Other Operating Expense |
353,800 | NA | 308,400 | 323,600 | 1,107,600 |
Operating Income Before Interest Expense |
1,402,300 | 880,000 | 762,000 | 850,200 | 805,500 |
Interest Expense, Net of Interest Capitalized |
76,600 | 68,500 | 64,400 | 59,300 | 59,600 |
Interest Expense (excl. Interest Capitalized) |
76,600 | 68,500 | 64,400 | 59,300 | 59,600 |
Operating Income After Interest Expense |
1,325,700 | 811,500 | 697,600 | 790,900 | 745,900 |
Miscellaneous Non Operating Expense |
0 | 0 | 0 | 0 | -137,000 |
Equity in Affiliates (Pretax) |
0 | 0 | 0 | 0 | 0 |
Unusual Expense |
93,200 | 37,200 | 1,900 | 6,600 | 2,000 |
Pretax Income |
291,100 | 774,300 | 695,700 | 784,300 | 606,900 |
Income Taxes |
101,000 | 275,100 | 238,100 | 273,300 | 234,300 |
Equity in Affiliates |
0 | 0 | 0 | 0 | 0 |
Consolidated Net Income |
190,100 | 499,200 | 457,600 | 511,000 | 372,600 |
Minority Interest Expense |
0 | 0 | 0 | 0 | 0 |
Net Income |
190,100 | 499,200 | 457,600 | 511,000 | 372,600 |
Extraordinaries & Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Net Income After Extraordinaries |
190,100 | 499,200 | 457,600 | 511,000 | 372,600 |
Preferred Dividends |
0 | 0 | 0 | 0 | 0 |
Net Inc. Avail. To Common - Basic |
190,100 | 499,200 | 457,600 | 511,000 | 372,600 |
Operational EPS |
0.74 | 1.55 | 1.33 | 1.45 | 1.02 |
EPS (basic) |
0.57 | 1.49 | 1.34 | 1.46 | 1.04 |
Common Shares Outstanding |
345,000 | 338,600 | 346,200 | 356,800 | 365,294 |
Basic Shares Outstanding |
340,100 | 334,800 | 341,700 | 350,300 | 358,269 |
Diluted Shares Outstanding |
345,000 | 338,600 | 346,200 | 356,800 | 365,294 |
Diluted EPS after Extraordinary Items |
0.55 | 1.47 | 1.32 | 1.43 | 1.02 |
Discont. Operations Per Share |
0 | 0 | 0 | 0 | 0 |
Continued operations EPS |
0.56 | 1.49 | 1.32 | 1.44 | 1.02 |
*Figures in thousands of U.S. Dollars except shares outstanding.
